Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Ian Naya"'
Autor:
Dave Singh, Gerard J. Criner, Ian Naya, Paul W. Jones, Lee Tombs, David A. Lipson, MeiLan K. Han
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-13 (2020)
Abstract Given the heterogeneity of chronic obstructive pulmonary disease (COPD), personalized clinical management is key to optimizing patient outcomes. Important treatment goals include minimizing disease activity and preventing disease progression
Externí odkaz:
https://doaj.org/article/92a883a1fd144981937dfeb59dc62e36
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-11 (2019)
Abstract Background Symptomatic patients with chronic obstructive pulmonary disease (COPD) and low exacerbation risk still have disease instability, which can be improved with better bronchodilation. We evaluated two long-acting bronchodilators indiv
Externí odkaz:
https://doaj.org/article/94c341298a4244f4829f3db0494927ad
Autor:
Dhvani Shah, Maurice Driessen, Nancy Risebrough, Timothy Baker, Ian Naya, Andrew Briggs, Afisi S. Ismaila
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 16, Iss 1, Pp 1-10 (2018)
Abstract Background Cost-effectiveness of once-daily umeclidinium bromide (UMEC) was compared with once-daily tiotropium (TIO) and once-daily glycopyrronium (GLY) in patients with chronic obstructive pulmonary disease (COPD) from a UK National Health
Externí odkaz:
https://doaj.org/article/9f617592621f49199211fa6da830622f
Correction to: Measuring disease activity in COPD: is clinically important deterioration the answer?
Autor:
Dave Singh, Gerard J. Criner, Ian Naya, Paul W. Jones, Lee Tombs, David A. Lipson, MeiLan K. Han
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/bc18cf0abc8049578a93e19a591e367f
Publikováno v:
Respiratory Research, Vol 18, Iss 1, Pp 1-9 (2017)
Abstract Background Reducing rescue medication use is a guideline-defined goal of asthma treatment, however, little is known about the validity of rescue medicine use as a marker of symptoms in chronic obstructive pulmonary disease (COPD). To improve
Externí odkaz:
https://doaj.org/article/ed453598e4814e1c85f54ee7c323af5e
Autor:
Ian Naya, Chris Compton, Afisi S. Ismaila, Ruby Birk, Noushin Brealey, Maggie Tabberer, Chang-Qing Zhu, David A. Lipson, Gerard Criner
Publikováno v:
ERJ Open Research, Vol 4, Iss 4 (2018)
Clinically important deterioration (CID) is a novel composite end-point (lung function, health status, exacerbations) for assessing disease stability in patients with chronic obstructive pulmonary disease (COPD). We prospectively analysed CID in the
Externí odkaz:
https://doaj.org/article/1c24a94a5bb24daeb8ac4f1810b76339
Autor:
Paul W. Jones, François Maltais, Claus Vogelmeier, David A. Lipson, Chris Compton, Ian Naya, Lee Tombs, Leif Bjermer, Edward Kerwin, Isabelle Boucot
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Leif Bjermer,1 Isabelle H Boucot,2 François Maltais,3 Edward M Kerwin,4 Ian P Naya,2 Lee Tombs,5 Paul W Jones,2 Chris Compton,2 David A Lipson,6,7 Claus F Vogelmeier8 1Respiratory Medicine and Allergology, Lund University, Lund, Sweden; 2Global Sp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c57822c528d78c7178cf59ab234cfa6
https://openaccess.sgul.ac.uk/id/eprint/113435/6/COPD-291751-dual-bronchodilator-therapy-as-first-line-treatment-in-maint.pdf
https://openaccess.sgul.ac.uk/id/eprint/113435/6/COPD-291751-dual-bronchodilator-therapy-as-first-line-treatment-in-maint.pdf
Autor:
Ian Naya, Isabelle Boucot, Leif Bjermer, Edward Kerwin, David A. Lipson, Lee Tombs, François Maltais, Claus Vogelmeier, Chris Compton, Paul W. Jones
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Claus F Vogelmeier,1 Ian P Naya,2,3 François Maltais,4 Leif Bjermer,5 Edward M Kerwin,6 Lee Tombs,7 Paul W Jones,2 Chris Compton,2 David A Lipson,8,9 Isabelle H Boucot2,10 1Department of Medicine, Pulmonary and Critical Care Medicine, University Med
Autor:
Afisi S. Ismaila, Andrew Briggs, Nancy Risebrough, V. Paly, Maurice Driessen, Necdet B Gunsoy, Ian Naya
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Victoria Federico Paly,1 Ian Naya,2 Necdet B Gunsoy,3 Maurice T Driessen,4 Nancy Risebrough,5 Andrew Briggs,6 Afisi S Ismaila7,81ICON Health Economics, ICON, Philadelphia, PA, USA; 2Global Respiratory Franchise, GSK, Brentford, Middlesex, UK; 3Value
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-11 (2019)
Respiratory Research
Respiratory Research
Background Symptomatic patients with chronic obstructive pulmonary disease (COPD) and low exacerbation risk still have disease instability, which can be improved with better bronchodilation. We evaluated two long-acting bronchodilators individually a